Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells (Q38906716)

7 September 2017

Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells (English)

1 reference

7 September 2017

0 references

1 reference

ChEBI release 2020-05-28

7

1 reference

7 September 2017

8

1 reference

Shailendra Anoopkumar-Dukie

7 September 2017

11

object named as

Shailendra Anoopkumar-Dukie

0 references

Amelia J McFarland

object named as

Amelia J McFarland

3

0 references

Anthony Perkins

object named as

Anthony V Perkins

6

0 references

author name string

Rebecca D Pickard

1

1 reference

7 September 2017

Briohny H Spencer

2

1 reference

7 September 2017

Nijole Bernaitis

4

1 reference

7 September 2017

Andrew K Davey

5

1 reference

7 September 2017

Amanda Forbes

9

1 reference

7 September 2017

David Christie

10

1 reference

7 September 2017

language of work or name

1 reference

24 February 2015

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

7 September 2017

1 reference

7 September 2017

388

1 reference

7 September 2017

7

1 reference

7 September 2017

793-799

1 reference

https://scigraph.springernature.com/pub.10.1007/s00210-015-1104-7

7 September 2017

0 references

cites work

Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Autophagy in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Autophagy as a cell death and tumor suppressor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Mode of action of docetaxel - a basis for combination with novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Inhibitors of phosphatidylinositol 3'-kinases promote mitotic cell death in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Cell biology. Promoting tumorigenesis by suppressing autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Self-consumption: the interplay of autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Inhibition of autophagy by 3-methyladenine protects 1321N1 astrocytoma cells against pyocyanin- and 1-hydroxyphenazine-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Paradoxical role of 3-methyladenine in pyocyanin-induced toxicity in 1321N1 astrocytoma and SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Docetaxel versus paclitaxel for antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-015-1104-7

10.1007/S00210-015-1104-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

0 references

1 reference